Has the FDA dropped the ball with accelerated approval of drugs? Elizabeth Tracey reports
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
The Alzheimer’s drug Aduhelm is just the latest misstep in the FDA’s mishandling of accelerated approval, with a recent study showing that almost half of drugs approved this way haven’t done the required confirmatory studies. Caleb Alexander, an internal medicine …